Cargando…

Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines

Objective To identify the number of drug-disease and drug-drug interactions for exemplar index conditions within National Institute of Health and Care Excellence (NICE) clinical guidelines. Design Systematic identification, quantification, and classification of potentially serious drug-disease and d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dumbreck, Siobhan, Flynn, Angela, Nairn, Moray, Wilson, Martin, Treweek, Shaun, Mercer, Stewart W, Alderson, Phil, Thompson, Alex, Payne, Katherine, Guthrie, Bruce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356453/ https://www.ncbi.nlm.nih.gov/pubmed/25762567 http://dx.doi.org/10.1136/bmj.h949

Ejemplares similares

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

Recreational drugs and HIV in Europe: current use of recreational drugs and principal HIV guidelines related recommendations
por: Garin Escriva, Noe, et al.
Publicado: (2014)

Managing Conflicts of Interest in the UK National Institute for Health and Care Excellence (NICE) Clinical Guidelines Programme: Qualitative Study
por: Graham, Tanya, et al.
Publicado: (2015)

A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets in primary medical care: The DQIP study protocol
por: Dreischulte, Tobias, et al.
Publicado: (2012)

EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations
por: Boesen, Kim, et al.
Publicado: (2021)

Oncology drug health technology assessment recommendations: Canadian versus UK experiences
por: Chabot, Isabelle, et al.
Publicado: (2014)

National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated Approval
por: Cliff, Edward R. Scheffer, et al.
Publicado: (2023)

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
por: Guthrie, Bruce, et al.
Publicado: (2015)

Turning evidence into recommendations: Protocol of a study guideline development groups
por: Michie, Susan, et al.
Publicado: (2007)

Study protocol of a mixed-methods evaluation of a cluster randomized trial to improve the safety of NSAID and antiplatelet prescribing: data-driven quality improvement in primary care
por: Grant, Aileen, et al.
Publicado: (2012)

Pharmacotherapy of atopic eczema - an analysis of the discrepancies between recent expert guidelines, official drug licenses, and evidence for efficacy of recommended drugs
por: Kordus, Katarzyna, et al.
Publicado: (2015)

Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
por: Li, Guangyao, et al.
Publicado: (2022)

Computational Drug Repurposing Based on a Recommendation System and Drug–Drug Functional Pathway Similarity
por: Shao, Mengting, et al.
Publicado: (2022)

Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting
por: Grant, Aileen, et al.
Publicado: (2013)

Drug safety guidelines: Are they effective?
por: Ahmad, Akram, et al.
Publicado: (2013)

Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)
por: Yamakawa, Kazuma, et al.
Publicado: (2021)

Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (July 2022)
por: Yamakawa, Kazuma, et al.
Publicado: (2022)

Physical Frailty and Use of Guideline‐Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction
por: Kondo, Toru, et al.
Publicado: (2023)

Updated recommendations: an assessment of NICE clinical guidelines
por: Martínez García, Laura, et al.
Publicado: (2014)

The U.S. Food and Drug Administration: Drug Information Resource for Formulary Recommendations
por: Marchand, Heidi C., et al.
Publicado: (2012)

The Microscopical Examination of Foods and Drugs
por: Charteris, F. J.
Publicado: (1903)

Recommender Systems in Antiviral Drug Discovery
por: Sosnina, Ekaterina A., et al.
Publicado: (2020)

How much is the lack of retention evidence costing trial teams in Ireland and the UK?
por: Murphy, Ellen, et al.
Publicado: (2022)

Case of Emphysema, without Local Injury
por: Dumbreck, William
Publicado: (1829)

Pharmacoeconomic Evaluations: Guidelines for Drug Purchasers
por: Langley, Paul C., et al.
Publicado: (2020)

An ethical analysis of UK drug policy as an example of a criminal justice approach to drugs: a commentary on the short film Putting UK Drug Policy into Focus
por: Holland, Adam
Publicado: (2020)

Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations
por: Monge, Susana, et al.
Publicado: (2014)

Race and Drug Toxicity: A Study of Three Cardiovascular Drugs with Strong Pharmacogenetic Recommendations
por: O’Brien, Travis J., et al.
Publicado: (2021)

Older Patients’ Compliance with Drug Storage Recommendations
por: Vlieland, Nicolaas D., et al.
Publicado: (2018)

Kernelized rank learning for personalized drug recommendation
por: He, Xiao, et al.
Publicado: (2018)

A drug recommender system for the treatment of hypertension
por: Mai, Arthur, et al.
Publicado: (2023)

Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines?
por: Mohammed, Baba Sulemana, et al.
Publicado: (2020)

Psychotropic drug treatment for agitated behaviour in dementia: what if the guideline prescribing recommendations are not sufficient? A qualitative study
por: Dijk, Margaretha T, et al.
Publicado: (2022)

Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230]
por: Fretheim, Atle, et al.
Publicado: (2003)

Bringing microbiome-drug interaction research into the clinic
por: Guthrie, Leah, et al.
Publicado: (2019)

Guidelines for Choosing Drugs in Chronic Heart Failure
por: Tabrizchi, Reza
Publicado: (2005)

Challenges and guidelines for clinical trial of herbal drugs
por: Parveen, Abida, et al.
Publicado: (2015)

Guidelines for clinical evaluation of anti‐cancer drugs
por: Minami, Hironobu, et al.
Publicado: (2021)

‘It's trying to manage the work’: a qualitative evaluation of recruitment processes within a UK multicentre trial
por: Skea, Zoë Christina, et al.
Publicado: (2017)

Drug-Induced Nephrotoxicity and Dose Adjustment Recommendations: Agreement Among Four Drug Information Sources
por: Bicalho, Millena Drumond, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6bc30n9pr4bjkvvqjp549gl1mt